Modified absorption formulation of gaboxadol

Mie Larsen (Inventor), Carsten Uhd Nielsen (Inventor), Birger Brodin Larsen (Inventor), Rene Holm (Inventor)

Research output: Patent

Abstract

The present invention relates to a pharmaceutical composition comprising gaboxadol or a pharmaceutically acceptable salt thereof and one or more inhibitors of PAT1 and/or one or more inhibitors of OAT. The present invention further relates to a pharmaceutical composition comprising from about 0.5 mg to about 50 mg gaboxadol or a pharmaceutically acceptable salt thereof, wherein the composition provides an in vivo plasma profile comprising a mean Tmax which is longer than about 20 minutes.

Original languageEnglish
IPCC07D 498/ 02 A I
Patent numberUS2009143335
Country/TerritoryDenmark
Priority date17/10/2008
Priority numberUS20080253879
Publication statusPublished - 4. Jun 2009
Externally publishedYes

Fingerprint

Dive into the research topics of 'Modified absorption formulation of gaboxadol'. Together they form a unique fingerprint.

Cite this